Thank you.
You insisted a lot in your earlier testimony on the importance of the technology transfer as being an essential ingredient in order to have more equitable global access to vaccines.
Is there anything in the current mutation of what the waiver proponents are asking for that would allow or require that technology transfer or what we're talking about exclusively, the waiver of intellectual property rights?